{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:05:32Z","timestamp":1793502332511,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ultragenyx Pharmaceuticals"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DK78775"],"award-info":[{"award-number":["R01 DK78775"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.pcl.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:30:43Z","timestamp":1514507443000},"page":"317-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Inborn Errors of Metabolism with Myopathy"],"prefix":"10.1016","volume":"65","author":[{"given":"Areeg","family":"El-Gharbawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2017.11.006_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cvr\/26.10.913","article-title":"The diabetic heart: metabolic causes for the development of a cardiomyopathy","volume":"26","author":"Rodrigues","year":"1992","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcl.2017.11.006_bib2","first-page":"340849","article-title":"Inborn errors of energy metabolism associated with myopathies","volume":"2010","author":"Das","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.pcl.2017.11.006_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pcl.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1023\/A:1005504223140","article-title":"Disorders of mitochondrial fatty acyl-CoA \u03b2-oxidation","volume":"22","author":"Wanders","year":"1999","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pcl.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jpeds.2010.04.063","article-title":"Tandem mass spectrometry screening for very long-chain acyl-CoA dehydrogenase deficiency: the value of second-tier enzyme testing","volume":"157","author":"Spiekerkoetter","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10545-010-9208-1","article-title":"Update on mitochondrial fatty acid oxidation disorders","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ppedcard.2007.08.013","article-title":"Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy","volume":"24","author":"Cox","year":"2007","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.pcl.2017.11.006_bib9","first-page":"5","article-title":"Chemiosmotic coupling in energy transduction: a logical development of biochemical knowledge","volume":"3","author":"Mitchell","year":"1972","journal-title":"J\u00a0Bioenerg"},{"key":"10.1016\/j.pcl.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2007-971921","article-title":"Fat metabolism during exercise: a review\u2014part II: regulation of metabolism and the effects of training","volume":"19","author":"Jeukendrup","year":"1998","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.pcl.2017.11.006_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders","volume":"64","author":"Rinaldo","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pcl.2017.11.006_bib12","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.rdc.2011.01.004","article-title":"Metabolic myopathies: clinical features and diagnostic approach","volume":"37","author":"Smith","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.pcl.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"67R","DOI":"10.1093\/glycob\/cwg077","article-title":"Glycobiology of neuromuscular disorders","volume":"13","author":"Martin","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.pcl.2017.11.006_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddmec.2009.02.001","article-title":"Carnitine homeostasis, mitochondrial function, and cardiovascular disease","volume":"6","author":"Sharma","year":"2009","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1016\/j.pcl.2017.11.006_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1203\/00006450-199009000-00020","article-title":"Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy","volume":"28","author":"Tein","year":"1990","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcl.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","article-title":"Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment - a retrospective chart review","volume":"116","author":"Vockley","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2016.08.008","article-title":"Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders","volume":"119","author":"Vockley","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4330\/wjc.v6.i11.1149","article-title":"The infant with cardiomyopathy: when to suspect inborn errors of metabolism?","volume":"26","author":"Byers","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.pcl.2017.11.006_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10545-010-9188-1","article-title":"Current issues regarding treatment of mitochondrial fatty acid oxidation disorders","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10545-010-9090-x","article-title":"Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1067\/mhj.2000.103935","article-title":"Cardiomyopathy in childhood, mitochondrial dysfunction and the role of L-carnitine","volume":"139","author":"Winter","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcl.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/hmg\/8.4.655","article-title":"Mutations of OCTN2, an organic cation\/carnitine transporter, lead to a deficient cellular carnitine uptake in primary carnitine deficiency","volume":"8","author":"Tang","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pcl.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1024481016187","article-title":"Carnitine transport: pathophysiology and metabolism of known molecular defects","volume":"26","author":"Tein","year":"2003","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3476(97)70171-9","article-title":"Sudden neonatal death in carnitine transporter deficiency","volume":"131","author":"Rinaldo","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.410300512","article-title":"Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake","volume":"30","author":"Stanley","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pcl.2017.11.006_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.10585","article-title":"Novel OCTN2 mutations: no genotype\u2013phenotype correlations: early carnitine therapy prevents cardiomyopathy","volume":"111","author":"Lamhonwah","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pcl.2017.11.006_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1540-8159.2004.00507.x","article-title":"Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2 deficiency in adolescence","volume":"27","author":"Rijlaarsdam","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.pcl.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142C","author":"Longo","year":"2006","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.pcl.2017.11.006_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-007-0527-9","article-title":"Carnitine transporter and holocarboxylase synthetase deficiencies in the Faroe Islands","volume":"30","author":"Lund","year":"2007","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine-metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pcl.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effect on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.mam.2004.06.007","article-title":"Carnitine acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects","volume":"25","author":"Rubio-Gozalbo","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pcl.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00711805","article-title":"Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis","volume":"17","author":"Brivet","year":"1994","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1005546408659","article-title":"Carnitine-acylcarnitine translocase deficiency is a treatable disease","volume":"22","author":"Al Aqeel","year":"1999","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/geno.1994.1605","article-title":"Assignment of the human carnitine palmitoyltransferase II gene (CPT11) to chromosome 1p32","volume":"24","author":"Gellera","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.pcl.2017.11.006_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/humu.10201","article-title":"Correlation between genotype, metabolic data and clinical presentation in carnitine palmitoyl transferase 2 (CPT2) deficiency","volume":"21","author":"Thuillier","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pcl.2017.11.006_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymgme.2008.05.002","article-title":"CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyl transferase II deficiency","volume":"94","author":"Isackson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/01.WNL.0000055901.58642.48","article-title":"Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients","volume":"60","author":"Wieser","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pcl.2017.11.006_bib39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmityl transferase deficiency and myoglobinuria","volume":"182","author":"Di Mauro","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.pcl.2017.11.006_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0733-8619(05)70179-1","article-title":"The molecular diagnosis of metabolic myopathies","volume":"18","author":"Vladutiu","year":"2000","journal-title":"Neurol Clin"},{"key":"10.1016\/j.pcl.2017.11.006_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pcl.2017.11.006_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1023\/A:1025947930752","article-title":"Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency","volume":"26","author":"Olpin","year":"2003","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2006.06.004","article-title":"Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3 hydroxyl acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency","volume":"89","author":"Gillingham","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: rhabdomyolysis \u2013 an overview for clinicians","volume":"9","author":"Huerta-Alard\u00edn","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.pcl.2017.11.006_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0021-9258(18)48391-3","article-title":"Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase","volume":"267","author":"Uchida","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pcl.2017.11.006_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/302261","article-title":"Clear correlation of genotype with disease phenotype in very-long chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Andresen","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pcl.2017.11.006_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01799421","article-title":"The mutational spectrum in very long-chain acyl-CoA dehydrogenase deficiency","volume":"19","author":"Andresen","year":"1996","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0925-4439(93)90058-9","article-title":"Very long chain acyl-CoA dehydrogenase deficiency: identification a new inborn error of mitochondrial fatty acid oxidation in fibroblasts","volume":"1180","author":"Bertrand","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pcl.2017.11.006_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-8981(97)00185-X","article-title":"Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients","volume":"269","author":"Vianey-Saban","year":"1998","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pcl.2017.11.006_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ymgme.2005.12.012","article-title":"VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis","volume":"88","author":"Boneh","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.pcl.2017.11.006_bib52","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0002-8223(02)90386-X","article-title":"Management of fatty acid oxidation disorders: a survey of current treatment strategies","volume":"102","author":"Solis","year":"2002","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.pcl.2017.11.006_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2011.09.030","article-title":"Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation","volume":"105","author":"Behrend","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymgme.2008.09.008","article-title":"Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency","volume":"96","author":"Arnold","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pcl.2017.11.006_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1023\/A:1005556207210","article-title":"Recognition and management of fatty acid oxidation defects : a series of 107 patients","volume":"22","author":"Saudubray","year":"1999","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jpeds.2005.12.028","article-title":"The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome","volume":"148","author":"Derks","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.11.006_bib58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3476(94)70363-9","article-title":"Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children","volume":"124","author":"Iafolla","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.11.006_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.58.2.209","article-title":"Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency","volume":"58","author":"Ruitenbeek","year":"1995","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pcl.2017.11.006_bib60","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10545-009-1202-0","article-title":"Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD)","volume":"32","author":"Lang","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib61","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM198811173192003","article-title":"Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine","volume":"319","author":"Rinaldo","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2017.11.006_bib62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0006-291X(92)91350-Y","article-title":"Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid \u03b2-oxidation","volume":"188","author":"Wanders","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pcl.2017.11.006_bib63","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1373\/clinchem.2005.062000","article-title":"Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene","volume":"52","author":"Das","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.pcl.2017.11.006_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pediatrneurol.2008.12.017","article-title":"Mitochondrial trifunctional protein deficiency with recurrent rhabdomyolysis","volume":"40","author":"Scheuerman","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pcl.2017.11.006_bib65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1067\/mpd.2003.231","article-title":"Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement","volume":"142","author":"Den Boer","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.11.006_bib66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1203\/01.PDR.0000103931.80055.06","article-title":"General mitochondrial trifunctional protein (TFP) deficiency as a result of either \u03b1- or \u03b2-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover","volume":"55","author":"Spiekerkoetter","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcl.2017.11.006_bib67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1203\/00006450-198407000-00020","article-title":"Glutaric aciduria type II: evidence for a defect related to the electron transfer flavoprotein or its dehydrogenase","volume":"18","author":"Christensen","year":"1984","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcl.2017.11.006_bib68","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2357","article-title":"Defects of electron transfer flavoprotein and electron transfer flavoprotein ubiquinone oxidoreductase: glutaric acidaemia type II","author":"Frerman","year":"2001"},{"key":"10.1016\/j.pcl.2017.11.006_bib69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/B:BOLI.0000042986.10291.e9","article-title":"Lipid-storage myopathy and\u00a0respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency","volume":"27","author":"Olsen","year":"2004","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib70","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pcl.2017.11.006_bib71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/jnnp.2009.176404","article-title":"Riboflavin-responsive lipid storage myopathy caused by ETFDH gene mutations","volume":"81","author":"Wen","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pcl.2017.11.006_bib72","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETF-DH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pcl.2017.11.006_bib73","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-008-0990-y","article-title":"Mitochondrial fatty acid oxidation defects remaining challenges","volume":"31","author":"Gregersen","year":"2008","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.pcl.2017.11.006_bib74","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(03)13105-4","article-title":"D,L-3-Hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)","volume":"361","author":"Van Hove","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2017.11.006_bib75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI0215311","article-title":"Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride","volume":"110","author":"Roe","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pcl.2017.11.006_bib76","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/hmg\/ddi303","article-title":"Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders","volume":"14","author":"Djouadi","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pcl.2017.11.006_bib77","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/522375","article-title":"Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy","volume":"81","author":"Gobin-Limballe","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pcl.2017.11.006_bib78","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","article-title":"Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial","volume":"82","author":"Orngreen","year":"2014","journal-title":"Neurology"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395517301815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395517301815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T13:15:12Z","timestamp":1660223712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395517301815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0031395517301815"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2017.11.006","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn Errors of Metabolism with Myopathy","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}